Literature DB >> 16493582

Matrix metalloproteinases in bone marrow: roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies.

X F Yu1, Z C Han.   

Abstract

Turnover balance of extracellular matrix (ECM) is a prerequisite for the structural and functional homeostasis of bone marrow (BM) microenvironment. The role of ECM in physiologic hematopoiesis and its pathologic change in hematopoietic malignancies are very important and under extensive investigation. Accumulating evidence suggests that matrix metalloproteinases (MMPs), a family of zinc-dependent proteinases, take an active part in the physiological and pathological hematopoiesis through remodeling the ECM in BM hematopoietic microenvironment. In this review, we will focus on the roles of MMPs in physiological hematopoiesis, hematopoietic stem cells mobilization/transplantation, and hematological malignancies. Furthermore, the preclinical studies on the role of synthetic MMP inhibitors in the treatment of hematological malignancies will be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493582     DOI: 10.14670/HH-21.519

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  14 in total

1.  Fish Oil-Rich Diet Promotes Hematopoiesis and Alters Hematopoietic Niche.

Authors:  Sheng Xia; Xiao-ping Li; Lu Cheng; Mu-tian Han; Miao-miao Zhang; Qi-xiang Shao; Hua-xi Xu; Ling Qi
Journal:  Endocrinology       Date:  2015-06-10       Impact factor: 4.736

Review 2.  Alcohol abuse and disorder of granulopoiesis.

Authors:  Xin Shi; Angelo L DeLucia; Jianxin Bao; Ping Zhang
Journal:  Pharmacol Ther       Date:  2019-03-01       Impact factor: 12.310

Review 3.  The progress of angiogenic factors in the development of leukemias.

Authors:  Yang Han; Xidi Wang; Bingping Wang; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2016-02

Review 4.  The extracellular matrix of hematopoietic stem cell niches.

Authors:  Cornelia Lee-Thedieck; Peter Schertl; Gerd Klein
Journal:  Adv Drug Deliv Rev       Date:  2021-11-25       Impact factor: 15.470

5.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

Review 6.  Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.

Authors:  Orit Jacobson; Xiaoyuan Chen
Journal:  Pharmacol Rev       Date:  2013-09-24       Impact factor: 25.468

7.  A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells.

Authors:  M Braig; N Pällmann; M Preukschas; D Steinemann; W Hofmann; A Gompf; T Streichert; T Braunschweig; M Copland; K L Rudolph; C Bokemeyer; S Koschmieder; A Schuppert; S Balabanov; T H Brümmendorf
Journal:  Leukemia       Date:  2014-03-07       Impact factor: 11.528

8.  Importance of Altered Gene Expression of Metalloproteinases 2, 9, and 16 in Acute Myeloid Leukemia: Preliminary Study.

Authors:  Jacek Pietrzak; Marek Mirowski; Rafał Świechowski; Damian Wodziński; Agnieszka Wosiak; Katarzyna Michalska; Ewa Balcerczak
Journal:  J Oncol       Date:  2021-05-06       Impact factor: 4.375

9.  Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.

Authors:  Sandrine Bouchet; Brigitte Bauvois
Journal:  Cancers (Basel)       Date:  2014-04-04       Impact factor: 6.639

10.  Altered gene expression patterns of innate and adaptive immunity pathways in transgenic rainbow trout harboring Cecropin P1 transgene.

Authors:  Jay H Lo; Chun-Mean Lin; Maria J Chen; Thomas T Chen
Journal:  BMC Genomics       Date:  2014-10-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.